Patents by Inventor Harri Jukarainen
Harri Jukarainen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20110172593Abstract: The present invention relates to an inserter for an intrauterine system, comprising a handle (3) having a longitudinal opening (8) at its first end, said opening (8) having a longitudinal axis parallel to the longitudinal axis of the inserter, a first end (8a) and a second end (8b), a movable slider (5) arranged in said longitudinal opening (8) and having a first end (5a) and a second end (5b), a plunger (2) attached to the handle (3) and having a longitudinal axis, and an insertion tube (6) having a first end, a second end and a longitudinal axis essentially parallel to the longitudinal axis of the plunger (2), the insertion tube (6) being, along said longitudinal axis, movably arranged around the plunger (2).Type: ApplicationFiled: September 11, 2009Publication date: July 14, 2011Inventors: Heikki Lyyikäinen, Iikka Jutila, Calvo Alonson, Harri Jukarainen, Taina Tjäder, Andrew Macleod, Michael Noble, David Whitaker
-
Publication number: 20110166508Abstract: The present invention relates to an inserter for an intrauterine system comprising a handle (3), and an insertion tube (6) having a first end and a second end, and being arranged in connection with the handle. The inserter is characterized in that the first end of the insertion tube (6) comprises at least one frame slot for receiving a frame of the intrauterine system. The invention also relates to a kit comprising an inserter according to the present invention and an intrauterine system, wherein the intrauterine system (1) comprises a therapeutic component (1b) and a continuous, closed frame (1a), the therapeutic component (1b) being connected to the frame (1a) at least one point, and therapeutic component (1b) of the intrauterine system (1) is at least mainly arranged inside the first end of the insertion tube (6) and the frame (1a) of the intrauterine system (1) is at least mainly arranged outside the first end of the insertion tube (6).Type: ApplicationFiled: September 16, 2009Publication date: July 7, 2011Inventors: Heikki Lyytikäinen, Ilkka Jutila, Ulla Calvo Alonso, Harri Jukarainen, Taina Träder, Andrew Macleod, Michael Noble, David Whitaker
-
Publication number: 20110146693Abstract: The invention relates to a method for contraception and for reducing menstrual problems and inducing amenorrhea, wherein an intrauterine delivery device is used for the controlled release of a combination of progestogen or a drug having a progestogenic activity and at least one therapeutically active substance capable of preventing or suppressing abnormal and/or irregular endometrial bleeding over a prolonged period of time.Type: ApplicationFiled: July 1, 2009Publication date: June 23, 2011Inventors: Bernd Duesterberg, Manja Ahola, Jyrki Pihlaja, Heikki Lyytikäinen, Harri Jukarainen, Satu Kleemola, Tero Parkatti
-
Publication number: 20110056501Abstract: The present invention relates to novel intrauterine systems and to methods for manufacturing these systems. An intrauterine system according to the invention comprises a reservoir and a continuous, closed and flexible frame.Type: ApplicationFiled: April 1, 2009Publication date: March 10, 2011Applicant: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikäinen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjäder, Andrew Macleod, Michael Noble, David Whitaker
-
Publication number: 20100036079Abstract: The present invention relates to the use of tocopherol as a co-catalyst in the ring opening polymerisation of cyclic siloxanes. The present invention further relates to a method for manufacturing hydrophilic polysiloxanes, wherein a hydrido-containing cyclic siloxane is reacted with a hydrophilic molecule comprising a carbon-carbon double bond, having the general formula (I) H2C?CH—(CHR)n—O—(CHR1CR2R3)mR4 or (II) H2C?CH—(CHR)n—R5, wherein n is an integer from 0 to 4, m is an integer from 0 to 5, R, R1, R2, R3 and R4 are each independently hydrogen or a C1 to C6 alkyl, R5 is a saturated cyclic hydrocarbon containing carbonyl group, in the presence of a first catalyst to obtain a monomer, and polymerising said monomer in the presence of a second catalyst and tocopherol as a co-catalyst.Type: ApplicationFiled: March 11, 2008Publication date: February 11, 2010Inventors: Emilia Tiitinen, Harri Jukarainen
-
Patent number: 7294345Abstract: The invention relates to an otorhinological delivery device comprising at least one pharmaceutically active agent. According to the invention the device comprises a core comprising said at least one pharmaceutically active agent wherein said core is made of an elastomer composition selected from the group consisting of poly(dimethylsiloxane), a siloxane-based elastomer comprising 3,3,3-trifluoropropyl groups attached to the Siatoms of the siloxane units, a siloxane-based elastomer comprising poly(alkylene oxide) groups and mixtures thereof, and a membrane encasing said core, said membrane being made of a same or a different elastomer composition than said core, said elastomer composition being selected from the group consisting of poly(dimethylsiloxane), a siloxane-based elastomer comprising 3,3,3-trifluoropropyl groups attached to the Siatoms of the siloxane units, a siloxane-based elastomer comprising poly(alkylene oxide) groups and mixtures thereof.Type: GrantFiled: January 14, 2004Date of Patent: November 13, 2007Assignee: Schering OyInventors: Timo Haapakumpu, Harri Jukarainen, Juha Ala-Sorvari, Henry Rankonen, Frederik E. Riphagen, Wolfgang Arnold
-
Publication number: 20060067982Abstract: The invention relates to an otorhinological delivery device comprising at least one pharmaceutically active agent. According to the invention the device comprises a core comprising said at least one pharmaceutically active agent wherein said core is made of an elastomer composition selected from the group consisting of poly(dimethylsiloxane), a siloxane-based elastomer comprising 3,3,3-trifluoropropyl groups attached to the Siatoms of the siloxane units, a siloxane-based elastomer comprising poly(alkylene oxide) groups and mixtures thereof, and a membrane encasing said core, said membrane being made of a same or a different elastomer composition than said core, said elastomer composition being selected from the group consisting of poly(dimethylsiloxane), a siloxane-based elastomer comprising 3,3,3-trifluoropropyl groups attached to the Siatoms of the siloxane units, a siloxane-based elastomer comprising poly(alkylene oxide) groups and mixtures thereof.Type: ApplicationFiled: January 14, 2004Publication date: March 30, 2006Applicant: TIMO HAAPAKUMPU HARRI JUKARA JUHA ALA -SORVARI HENInventors: Timo Haapakumpu, Harri Jukarainen, Juha Ala-Sorvari, Frederik Riphagen, Wolfgang Arnold
-
Patent number: 6887948Abstract: The invention relates to a method for the preparation of a siloxane-based elastomer composition comprising at least one elastomer, said elastomer composition comprising poly(alkylene oxide) groups present in the elastomer as alkoxy-terminated grafts of polysiloxane units and linked to the polysiloxane units by silicon-carbon bonds wherein at least one vinyl functional polymer component is crosslinked in the presence of a peroxide catalyst.Type: GrantFiled: November 18, 2002Date of Patent: May 3, 2005Assignee: Schering OyInventors: Harri Jukarainen, Tommi Markkula, Juha Ala-Sorvari, Pirkko Lehtinen, Jarkko Ruohonen, Matti Lehtinen
-
Patent number: 6794464Abstract: A membrane or matrix for controlling the permeation rate of a drug, where the membrane or matrix includes a siloxane-based elastomer composition which contains at least one elastomer and optionally a non-crosslinked polymer. The elastomer composition includes poly(alkylene oxide) groups, and the poly(alkylene oxide) groups are present as blocks in a chain of the elastomer or the polymer, or as blocks and alkoxy-terminated grafts of polysiloxane units, the blocks or blocks and grafts being linked to the polysiloxane units by silicon-carbon bonds, with at least three blocks being present in the elastomer or polymer chain. Methods for the preparation of the elastomer composition are also disclosed.Type: GrantFiled: November 18, 2002Date of Patent: September 21, 2004Assignee: Schering OyInventors: Harri Jukarainen, Tommi Markkula, Juha Ala-Sorvari, Matti Lehtinen, Jarkko Ruohonen
-
Publication number: 20030096920Abstract: A membrane or matrix for controlling the permeation rate of a drug, where the membrane or matrix includes a siloxane-based elastomer composition which contains at least one elastomer and optionally a non-crosslinked polymer. The elastomer composition includes poly(alkylene oxide) groups, and the poly(alkylene oxide) groups are present as blocks in a chain of the elastomer or the polymer, or as blocks and alkoxy-terminated grafts of polysiloxane units, the blocks or blocks and grafts being linked to the polysiloxane units by silicon-carbon bonds, with at least three blocks being present in the elastomer or polymer chain. Methods for the preparation of the elastomer composition are also disclosed.Type: ApplicationFiled: November 18, 2002Publication date: May 22, 2003Inventors: Harri Jukarainen, Tommi Markkula, Juha Ala-Sorvari, Matti Lehtinen, Pirkko Lehtinen, Jarkko Ruohonen
-
Publication number: 20030096921Abstract: The invention relates to a method for the preparation of a siloxane-based elastomer composition comprising at least one elastomer, said elastomer composition comprising poly(alkylene oxide) groups present in the elastomer as alkoxy-terminated grafts of polysiloxane units and linked to the polysiloxane units by silicon-carbon bonds wherein at least one vinyl functional polymer component is crosslinked in the presence of a peroxide catalyst.Type: ApplicationFiled: November 18, 2002Publication date: May 22, 2003Inventors: Harri Jukarainen, Tommi Markkula, Juha Ala-Sorvari, Matti Lehtinen, Pirkko Lehtinen, Jarkko Ruohonen
-
Patent number: 6476079Abstract: A device for the controlled release over a prolonged period of time of a drug having antiprogestinic properties, the device including a core containing the drug, optionally a membrane encasing the core, where at least one of the core and membrane, when present, is made of a siloxane-based elastomer composition including at least one elastomer and optionally a non-crosslinked polymer. The device is characterized in that the elastomer composition includes poly(alkylene oxide) groups and that the poly(alkylene oxide) groups are present in the elastomer or polymer as alkoxy-terminated grafts of polysiloxane units, or as blocks, the grafts or blocks being linked to the polysiloxane units by silicon-carbon bonds, or as a mixture of these forms.Type: GrantFiled: December 23, 1999Date of Patent: November 5, 2002Assignee: Leiras OyInventors: Harri Jukarainen, Tommi Markkula, Juha Ala-sorvari, Matti Lehtinen, Jarkko Ruohonen
-
Patent number: 6300452Abstract: The invention relates to a new polysiloxane-based block copolymer having a formula T(AB)xAT (I) wherein A=—(SiR′R″O)nSiR′R″—, wherein R′ and R″ are the the same or different and represent a lower alkyl group or a phenyl group, wherein said alkyl or phenyl group may be substituted or unsubstituted; B is polyalkylene oxide of formula wherein R is hydrogen, lower alkyl, or phenyl; R1 is hydrogen or lower alkyl; y is 2-6; m is 1-30; n is 1-3000; and x is 0-100.Type: GrantFiled: November 18, 1999Date of Patent: October 9, 2001Assignee: Leiras OyInventors: Harri Jukarainen, Jarkko Ruohonen, Matti Lehtinen, Juha Ala-Sorvari, Jukka Seppälä
-
Patent number: D603038Type: GrantFiled: October 1, 2008Date of Patent: October 27, 2009Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612926Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612927Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612928Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612929Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612930Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker
-
Patent number: D612931Type: GrantFiled: September 11, 2009Date of Patent: March 30, 2010Assignee: Bayer Schering Pharma OyInventors: Pirjo Kortesuo, Ulla Calvo Alonso, Pirjo Inki, Harri Jukarainen, Ilkka Jutila, Juha Lehtinen, Eeva Lukkari-Lax, Heikki Lyytikainen, Joachim Moede, Hannu Nikander, Pirjo Sallinen, Taina Tjader, Andrew MacLeod, Michael Nobel, David Whitaker